Investor
GV
Named in 23 funding announcements in 2026: led 6 and joined 17, across 22 companies. Every round below links to the announcement that named them.
Also written as Google Ventures in the announcements.
For investors, banks and advisers
Want this delivered, filtered to your mandate?
Every morning: the rounds in your sectors, stages and regions. The investor index as an export. First access to what verified founders say their companies need next, on the founder's terms. Tell us what you are looking for and a person replies with what is available for your desk.
Where it invests
Sectors named in these rounds
Invests alongside
Named on the same announcements
Counted from the announcements only. Appearing on the same round is a fact about the round, not a statement about a relationship.
Rounds led
Where the announcement named GV as lead
| Company | Raised | Round | Announced | Co-led with | Source |
|---|---|---|---|---|---|
| Encoded Therapeutics USA | $275M | Series F | 2026-09-09 | co-led with another healthcare fund | announcement |
| Nebex USA | $30M | Seed | 2026-06-29 | announcement | |
| MokN UK | $15M | Series A | 2026-05-29 | announcement | |
| Recursive Superintelligence UK | $650M | Undisclosed | 2026-05-15 | co-led with Greycroft | announcement |
| SolveAI UK | $50M | Series A | 2026-03-09 | announcement | |
| Synthesia UK | $200M | Series E | 2026-01-27 | announcement |
Rounds joined
Where GV participated
| Company | Raised | Round | Announced | Led by | Source |
|---|---|---|---|---|---|
| Blacksmith USA | $66M | Series C | 2026-10-21 | led by Sequoia Capital | announcement |
| Estuary Biotherapeutics USA | $93M | Series A | 2026-10-19 | led by RA Capital Management | announcement |
| OMass Therapeutics UK | $310M | Series C | 2026-10-16 | led by Bain Capital Life Sciences | announcement |
| Armadin USA | $256M | Series B | 2026-10-01 | led by Andreessen Horowitz, Accel | announcement |
| Metaview UK | $60M | Series C | 2026-09-30 | led by Insight Partners | announcement |
| Snorkel AI USA | $350M | Series C | 2026-09-23 | led by Insight Partners, S32 | announcement |
| EnduroSat Bulgaria | $205M | Undisclosed | 2026-09-17 | led by Riot Ventures, Atreides Management | announcement |
| Blacksmith USA | $45M | Series B | 2026-08-12 | led by Peak XV Partners | announcement |
| LifeMine Therapeutics USA | $263M | Series E | 2026-08-07 | led by Milky Way Investments | announcement |
| Obsidian USA | $85M | Series D | 2026-08-04 | led by Crescent Cove Advisors | announcement |
| Oblenio Bio USA | $62M | Series B | 2026-06-25 | led by Pfizer Ventures | announcement |
| Verse USA | $54M | Series B | 2026-06-18 | led by Bessemer Venture Partners | announcement |
| Isomorphic Labs UK | $2.1B | Series B | 2026-05-12 | led by Thrive Capital | announcement |
| Lawhive UK | $60M | Series B | 2026-02-05 | led by Mitch Rales | announcement |
| Midi Health USA | $100M | Series D | 2026-02-03 | led by Goodwater Capital | announcement |
| Humans& USA | $480M | Seed | 2026-01-22 | led by SV Angel | announcement |
| OpenEvidence USA | $250M | Series D | 2026-01-21 | led by Thrive Capital, DST Global | announcement |
Investor names are read from the funding announcements and grouped by spelling. A round names its investors the way the publisher did; a firm not named in an announcement does not appear here. Corrections: info@afterraise.com.